Cargando…

Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model

Anxiety is a symptom of various mental disorders, including depression. Severe anxiety can significantly affect the quality of life. Hesperidin (Hes), a flavonoid found in the peel of citrus fruits, reportedly has various functional properties, one of which is its ability to relieve acute and chroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Takumi, Horita, Chihoko, Imagawa, Mikiya, Hibarino, Momoka, Tateno, Sayaka, Kubo, Yurina, Kawabe, Momoko, Morishita, Naoki, Endo, Shin, Shiozaki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470464/
https://www.ncbi.nlm.nih.gov/pubmed/37663268
http://dx.doi.org/10.3389/fphar.2023.1213252
_version_ 1785099683272589312
author Nishida, Takumi
Horita, Chihoko
Imagawa, Mikiya
Hibarino, Momoka
Tateno, Sayaka
Kubo, Yurina
Kawabe, Momoko
Morishita, Naoki
Endo, Shin
Shiozaki, Kazuhiro
author_facet Nishida, Takumi
Horita, Chihoko
Imagawa, Mikiya
Hibarino, Momoka
Tateno, Sayaka
Kubo, Yurina
Kawabe, Momoko
Morishita, Naoki
Endo, Shin
Shiozaki, Kazuhiro
author_sort Nishida, Takumi
collection PubMed
description Anxiety is a symptom of various mental disorders, including depression. Severe anxiety can significantly affect the quality of life. Hesperidin (Hes), a flavonoid found in the peel of citrus fruits, reportedly has various functional properties, one of which is its ability to relieve acute and chronic stress. However, Hes is insoluble in water, resulting in a low absorption rate in the body and low bioavailability. Glucosyl hesperidin (GHes) is produced by adding one glucose molecule to hesperidin. Its water solubility is significantly higher than that of Hes, which is expected to improve its absorption into the body and enhance its effects. However, its efficacy in alleviating anxiety has not yet been investigated. Therefore, in this study, the anxiolytic effects of GHes were examined in a zebrafish model of anxiety. Long-term administration of diets supplemented with GHes did not cause any toxicity in the zebrafish. In the novel tank test, zebrafish in the control condition exhibited an anxious behavior called freezing, which was significantly suppressed in GHes-fed zebrafish. In the black-white preference test, which also induces visual stress, GHes-fed zebrafish showed significantly increased swimming time in the white side area. Furthermore, in tactile (low water-level stress) and olfactory-mediated stress (alarm substance administration test) tests, GHes suppressed anxious behavior, and these effects were stronger than those of Hes. Increased noradrenaline levels in the brain generally cause freezing; however, in zebrafish treated with GHes, the amount of noradrenaline after stress was lower than that in the control group. Activation of c-fos/ERK/Th, which is upstream of the noradrenaline synthesis pathway, was also suppressed, while activation of the CREB/BDNF system, which is vital for neuroprotective effects, was significantly increased. These results indicate that GHes has a more potent anxiolytic effect than Hes in vivo, which may have potential applications in drug discovery and functional food development.
format Online
Article
Text
id pubmed-10470464
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104704642023-09-01 Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model Nishida, Takumi Horita, Chihoko Imagawa, Mikiya Hibarino, Momoka Tateno, Sayaka Kubo, Yurina Kawabe, Momoko Morishita, Naoki Endo, Shin Shiozaki, Kazuhiro Front Pharmacol Pharmacology Anxiety is a symptom of various mental disorders, including depression. Severe anxiety can significantly affect the quality of life. Hesperidin (Hes), a flavonoid found in the peel of citrus fruits, reportedly has various functional properties, one of which is its ability to relieve acute and chronic stress. However, Hes is insoluble in water, resulting in a low absorption rate in the body and low bioavailability. Glucosyl hesperidin (GHes) is produced by adding one glucose molecule to hesperidin. Its water solubility is significantly higher than that of Hes, which is expected to improve its absorption into the body and enhance its effects. However, its efficacy in alleviating anxiety has not yet been investigated. Therefore, in this study, the anxiolytic effects of GHes were examined in a zebrafish model of anxiety. Long-term administration of diets supplemented with GHes did not cause any toxicity in the zebrafish. In the novel tank test, zebrafish in the control condition exhibited an anxious behavior called freezing, which was significantly suppressed in GHes-fed zebrafish. In the black-white preference test, which also induces visual stress, GHes-fed zebrafish showed significantly increased swimming time in the white side area. Furthermore, in tactile (low water-level stress) and olfactory-mediated stress (alarm substance administration test) tests, GHes suppressed anxious behavior, and these effects were stronger than those of Hes. Increased noradrenaline levels in the brain generally cause freezing; however, in zebrafish treated with GHes, the amount of noradrenaline after stress was lower than that in the control group. Activation of c-fos/ERK/Th, which is upstream of the noradrenaline synthesis pathway, was also suppressed, while activation of the CREB/BDNF system, which is vital for neuroprotective effects, was significantly increased. These results indicate that GHes has a more potent anxiolytic effect than Hes in vivo, which may have potential applications in drug discovery and functional food development. Frontiers Media S.A. 2023-08-17 /pmc/articles/PMC10470464/ /pubmed/37663268 http://dx.doi.org/10.3389/fphar.2023.1213252 Text en Copyright © 2023 Nishida, Horita, Imagawa, Hibarino, Tateno, Kubo, Kawabe, Morishita, Endo and Shiozaki. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Nishida, Takumi
Horita, Chihoko
Imagawa, Mikiya
Hibarino, Momoka
Tateno, Sayaka
Kubo, Yurina
Kawabe, Momoko
Morishita, Naoki
Endo, Shin
Shiozaki, Kazuhiro
Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title_full Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title_fullStr Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title_full_unstemmed Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title_short Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
title_sort glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470464/
https://www.ncbi.nlm.nih.gov/pubmed/37663268
http://dx.doi.org/10.3389/fphar.2023.1213252
work_keys_str_mv AT nishidatakumi glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT horitachihoko glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT imagawamikiya glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT hibarinomomoka glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT tatenosayaka glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT kuboyurina glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT kawabemomoko glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT morishitanaoki glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT endoshin glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel
AT shiozakikazuhiro glucosylhesperidinexhibitsmorepotentanxiolyticactivitythanhesperidinaccompaniedbytheattenuationofnoradrenalineinductioninazebrafishmodel